A paper authored by Mihaela van der Schaar, Ahmed Alaa, and Dan Jarrett, alongside Prof. Stefan Scholtes from Cambridge Judge Business School and a number of the van der Schaar Lab’s clinical collaborators, has been published in Machine Learning (editor-in-chief: Hendrik Blockeel).
The paper, entitled “How Artificial Intelligence and Machine Learning Can Help Healthcare Systems Respond to COVID-19,” was published online on December 9.
The authors highlight the potential role to be played by machine learning and AI to serve as essential tools in support of in a rigorous clinical and societal response to the ongoing global pandemic (as well as future pandemics), and proposes a framework by which this could be achieved.
How Artificial Intelligence and Machine Learning
Can Help Healthcare Systems Respond to COVID-19
The COVID-19 global pandemic is a threat not only to the health of millions of individuals, but also to the stability of infrastructure and economies around the world.
The disease will inevitably place an overwhelming burden on healthcare systems that cannot be effectively dealt with by existing facilities or responses based on conventional approaches.
We believe that a rigorous clinical and societal response can only be mounted by using intelligence derived from a variety of data sources to better utilize scarce healthcare resources, provide personalized patient management plans, inform policy, and expedite clinical trials.
In this paper, we introduce five of the most important challenges in responding to COVID-19 and show how each of them can be addressed by recent developments in machine learning (ML) and artificial intelligence (AI). We argue that the integration of these techniques into local, national, and international healthcare systems will save lives, and propose specific methods by which implementation can happen swiftly and efficiently.
We offer to extend these resources and knowledge to assist policymakers seeking to implement these techniques.
For a full list of the van der Schaar Lab’s publications, click here.
To find out more about the van der Schaar Lab’s work related to the COVID-19 pandemic, visit our dedicated page here.